These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 16953233

  • 1. KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression.
    Oliveira C, Velho S, Moutinho C, Ferreira A, Preto A, Domingo E, Capelinha AF, Duval A, Hamelin R, Machado JC, Schwartz S, Carneiro F, Seruca R.
    Oncogene; 2007 Jan 04; 26(1):158-63. PubMed ID: 16953233
    [Abstract] [Full Text] [Related]

  • 2. Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer.
    Oliveira C, Velho S, Domingo E, Preto A, Hofstra RM, Hamelin R, Yamamoto H, Seruca R, Schwartz S.
    Oncogene; 2005 Nov 17; 24(51):7630-4. PubMed ID: 16007118
    [Abstract] [Full Text] [Related]

  • 3. Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases.
    Baldus SE, Schaefer KL, Engers R, Hartleb D, Stoecklein NH, Gabbert HE.
    Clin Cancer Res; 2010 Feb 01; 16(3):790-9. PubMed ID: 20103678
    [Abstract] [Full Text] [Related]

  • 4. BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAF(V600E) but not KRAS mutations.
    Preto A, Figueiredo J, Velho S, Ribeiro AS, Soares P, Oliveira C, Seruca R.
    J Pathol; 2008 Feb 01; 214(3):320-7. PubMed ID: 18098337
    [Abstract] [Full Text] [Related]

  • 5. Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation.
    Nagasaka T, Sasamoto H, Notohara K, Cullings HM, Takeda M, Kimura K, Kambara T, MacPhee DG, Young J, Leggett BA, Jass JR, Tanaka N, Matsubara N.
    J Clin Oncol; 2004 Nov 15; 22(22):4584-94. PubMed ID: 15542810
    [Abstract] [Full Text] [Related]

  • 6. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia.
    Yuen ST, Davies H, Chan TL, Ho JW, Bignell GR, Cox C, Stephens P, Edkins S, Tsui WW, Chan AS, Futreal PA, Stratton MR, Wooster R, Leung SY.
    Cancer Res; 2002 Nov 15; 62(22):6451-5. PubMed ID: 12438234
    [Abstract] [Full Text] [Related]

  • 7. Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression.
    Calistri D, Rengucci C, Seymour I, Lattuneddu A, Polifemo AM, Monti F, Saragoni L, Amadori D.
    J Cell Physiol; 2005 Aug 15; 204(2):484-8. PubMed ID: 15702478
    [Abstract] [Full Text] [Related]

  • 8. EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases.
    Schmid K, Oehl N, Wrba F, Pirker R, Pirker C, Filipits M.
    Clin Cancer Res; 2009 Jul 15; 15(14):4554-60. PubMed ID: 19584155
    [Abstract] [Full Text] [Related]

  • 9. Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer.
    Zlobec I, Kovac M, Erzberger P, Molinari F, Bihl MP, Rufle A, Foerster A, Frattini M, Terracciano L, Heinimann K, Lugli A.
    Int J Cancer; 2010 Dec 01; 127(11):2569-75. PubMed ID: 20162668
    [Abstract] [Full Text] [Related]

  • 10. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas.
    Chan TL, Zhao W, Leung SY, Yuen ST, Cancer Genome Project.
    Cancer Res; 2003 Aug 15; 63(16):4878-81. PubMed ID: 12941809
    [Abstract] [Full Text] [Related]

  • 11. Concordance in KRAS and BRAF mutations in endoscopic biopsy samples and resection specimens of colorectal adenocarcinoma.
    Krol LC, 't Hart NA, Methorst N, Knol AJ, Prinsen C, Boers JE.
    Eur J Cancer; 2012 May 15; 48(7):1108-15. PubMed ID: 22446020
    [Abstract] [Full Text] [Related]

  • 12. Consistent absence of BRAF mutations in cervical and endometrial cancer despite KRAS mutation status.
    Pappa KI, Choleza M, Markaki S, Giannikaki E, Kyroudi A, Vlachos G, Voulgaris Z, Anagnou NP.
    Gynecol Oncol; 2006 Mar 15; 100(3):596-600. PubMed ID: 16256179
    [Abstract] [Full Text] [Related]

  • 13. High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases.
    Fujiyoshi K, Yamamoto G, Takahashi A, Arai Y, Yamada M, Kakuta M, Yamaguchi K, Akagi Y, Nishimura Y, Sakamoto H, Akagi K.
    Oncol Rep; 2017 Feb 15; 37(2):785-792. PubMed ID: 28000889
    [Abstract] [Full Text] [Related]

  • 14. BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma.
    Costa AM, Herrero A, Fresno MF, Heymann J, Alvarez JA, Cameselle-Teijeiro J, García-Rostán G.
    Clin Endocrinol (Oxf); 2008 Apr 15; 68(4):618-34. PubMed ID: 18070147
    [Abstract] [Full Text] [Related]

  • 15. Prognostic Value of BRAF and KRAS Mutation in Relation to Colorectal Cancer Survival in Iranian Patients: Correlated to Microsatellite Instability.
    Nazemalhosseini-Mojarad E, Kishani Farahani R, Mehrizi M, Baghaei K, Yaghoob Taleghani M, Golmohammadi M, Peyravian N, Ashtari S, Pourhoseingholi MA, Asadzadeh Aghdaei H, Zali MR.
    J Gastrointest Cancer; 2020 Mar 15; 51(1):53-62. PubMed ID: 30635874
    [Abstract] [Full Text] [Related]

  • 16. B-Raf(V600E) cooperates with alternative spliced Rac1b to sustain colorectal cancer cell survival.
    Matos P, Oliveira C, Velho S, Gonçalves V, da Costa LT, Moyer MP, Seruca R, Jordan P.
    Gastroenterology; 2008 Sep 15; 135(3):899-906. PubMed ID: 18602919
    [Abstract] [Full Text] [Related]

  • 17. Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas.
    Fransén K, Klintenäs M, Osterström A, Dimberg J, Monstein HJ, Söderkvist P.
    Carcinogenesis; 2004 Apr 15; 25(4):527-33. PubMed ID: 14688025
    [Abstract] [Full Text] [Related]

  • 18. Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma.
    Kang S, Kim HS, Seo SS, Park SY, Sidransky D, Dong SM.
    Gynecol Oncol; 2007 Jun 15; 105(3):662-6. PubMed ID: 17360030
    [Abstract] [Full Text] [Related]

  • 19. Aberrant pattern of the cytokeratin 7/cytokeratin 20 immunophenotype in colorectal adenocarcinomas with BRAF mutations.
    Gurzu S, Jung I.
    Pathol Res Pract; 2012 Mar 15; 208(3):163-6. PubMed ID: 22361037
    [Abstract] [Full Text] [Related]

  • 20. Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer.
    Artale S, Sartore-Bianchi A, Veronese SM, Gambi V, Sarnataro CS, Gambacorta M, Lauricella C, Siena S.
    J Clin Oncol; 2008 Sep 01; 26(25):4217-9. PubMed ID: 18757341
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.